|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | |
| A61K 39/00 | |||
| A61K 39/395 |
| (11) | Number of the document | 3169362 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15760317.6 |
| Date of filing the European patent application | 2015-07-16 | |
| (97) | Date of publication of the European application | 2017-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/040765 |
| Date | 2015-07-16 |
| (87) | Number | WO 2016/011260 |
| Date | 2016-01-21 |
| (30) | Number | Date | Country code |
| 201462025371 P | 2014-07-16 | US | |
| 201462043167 P | 2014-08-28 | US | |
| 201462080725 P | 2014-11-17 | US | |
| 201562132709 P | 2015-03-13 | US | |
| 15305830 | 2015-05-29 | EP |
| (72) |
HANOTIN, Corinne, FR
BESSAC, Laurence, FR
CHAUDHARI, Umesh, US
PORDY, Robert, US
SCHWEMMER GIPE, Daniel A., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
Sanofi Biotechnology, 54 rue La Boétie, 75008 Paris, FR |
| (54) | METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA |
| METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA |